Article
Comprehensive Multiomic Analysis Identified TUBA1C as a Potential Prognostic Biological Marker of Immune-Related Therapy in Pan-Cancer.
Computational and mathematical methods in medicine - 1 Jan 2022
Zou Yiming, Wang Guoqing, Fan Min
Abstract excerpt
TUBA1C is correlated with an unfavourable prognosis and the infiltration of immune cells in several cancers. However, its function as a significant biomarker for the prognosis of immunotherapy in pan-cancer remains unclear. This study aims at assessing the role of TUBA1C in pan-cancer at multiple levels, including mutations, gene expression, methylation, m6A methylation, and immune cell infiltration levels. Data...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
